Company intelligence / Profile preview

metaBIX Biotech

Ownership: Private
Development stage: Commercial

Overview

metaBIX Biotech has developed an AI-powered diagnostic and environmental monitoring platform that predicts infectious disease outbreaks up to two weeks in advance. The system is designed for early warning and prevention across animal, plant, and human health sectors. The company is at an early stage with a focus on global expansion and impact.[1][4][5]

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic platformsEnvironmental biosurveillance technology
Industry: Molecular Diagnostics

Partnerships

The Ganesha Lab accelerator/incubator program participant[5]

Beyond the preview

Go deeper on metaBIX Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on metaBIX Biotech.

Explore the full profile